Page last updated: 2024-08-17

spironolactone and danazol

spironolactone has been researched along with danazol in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19903 (21.43)18.7374
1990's1 (7.14)18.2507
2000's4 (28.57)29.6817
2010's6 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Rosazza, JP; Smith, RV1
Biffignandi, P; Massucchetti, C; Molinatti, GM1
Curole, DN; Dickey, RP; Taylor, SN1
Johnson, SR1
Feyles, V; Gianetto-Berruti, A1
Hirvonen, J; Kangas, H; Kortejärvi, H; Lehto, P; Liimatainen, A; Ojala, K; Peltonen, L; Tanninen, VP1

Reviews

5 review(s) available for spironolactone and danazol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Microbial models for drug metabolism.
    Advances in applied microbiology, 1979, Volume: 25

    Topics: Acronine; Animals; Aporphines; Bacteria; Biotransformation; Cannabinoids; Chemical Phenomena; Chemistry; Cytochrome P-450 Enzyme System; Danazol; Daunorubicin; Ellipticines; Fungi; Indans; Mammals; Models, Biological; Oxidation-Reduction; Oxygenases; Papaverine; Pharmaceutical Preparations; Prostaglandins; Species Specificity; Spironolactone; Thiazoles; Yeasts

1979
[Intracellular and extracellular proteins binding androgenic hormones. Biochemical properties and clinical significance].
    Minerva medica, 1983, Mar-17, Volume: 74, Issue:11

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Androgen-Binding Protein; Androgen-Insensitivity Syndrome; Breast Neoplasms; Carrier Proteins; Danazol; Disorders of Sex Development; Female; Humans; Hyperthyroidism; Infertility, Male; Liver Cirrhosis; Male; Minoxidil; Receptors, Androgen; Sex Hormone-Binding Globulin; Spironolactone

1983
Premenstrual syndrome therapy.
    Clinical obstetrics and gynecology, 1998, Volume: 41, Issue:2

    Topics: Anti-Anxiety Agents; Anti-Inflammatory Agents, Non-Steroidal; Bromocriptine; Contraceptives, Oral, Combined; Danazol; Evidence-Based Medicine; Exercise Therapy; Fatty Acids, Essential; Female; gamma-Linolenic Acid; Gonadotropin-Releasing Hormone; Humans; Linoleic Acids; Oenothera biennis; Ovariectomy; Plant Oils; Premenstrual Syndrome; Progesterone; Progestins; Pyridoxine; Selective Serotonin Reuptake Inhibitors; Spironolactone; Vitamin E

1998
Premenstrual syndrome.
    Minerva ginecologica, 2002, Volume: 54, Issue:2

    Topics: Anti-Anxiety Agents; Clinical Trials as Topic; Contraceptives, Oral; Danazol; Diagnosis, Differential; Diet; Diuretics; Estrogen Antagonists; Exercise; Female; Gonadotropin-Releasing Hormone; Humans; Life Style; Mineralocorticoid Receptor Antagonists; Minerals; Plant Preparations; Premenstrual Syndrome; Progestins; Prospective Studies; Randomized Controlled Trials as Topic; Research; Selective Serotonin Reuptake Inhibitors; Spironolactone; Vitamins

2002

Other Studies

9 other study(ies) available for spironolactone and danazol

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
    Nature chemical biology, 2009, Volume: 5, Issue:10

    Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Serum estradiol and danazol. I. Endometriosis response, side effects, administration interval, concurrent spironolactone and dexamethasone.
    Fertility and sterility, 1984, Volume: 42, Issue:5

    Topics: Adult; Age Factors; Body Weight; Danazol; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Endometriosis; Estradiol; Female; Humans; Pelvic Neoplasms; Pregnadienes; Progesterone; Radioimmunoassay; Spironolactone

1984
Use of conventional surfactant media as surrogates for FaSSIF in simulating in vivo dissolution of BCS class II drugs.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2011, Volume: 78, Issue:3

    Topics: Absorption; Animals; Biopharmaceutics; Body Fluids; Computer Simulation; Danazol; Diuretics; Dogs; Estrogen Antagonists; Fasting; Female; Intestines; Male; Micelles; Pharmaceutical Preparations; Polysorbates; Sodium Dodecyl Sulfate; Solubility; Spironolactone; Surface-Active Agents

2011